Login

We are experiencing technical difficulties. Your form submission has not been successful. Please accept our apologies and try again later. Details: [details]

Download

Register

We are experiencing technical difficulties. Your form submission has not been successful. Please accept our apologies and try again later. Details: [details]

Download

Thank you for registering

An email to complete your account has been sent to

Return to the website

get direct access

Fill in your details below and get direct access to view content

Text error notification

Text error notification

Checkbox error notification

Checkbox error notification

We are experiencing technical difficulties. Your form submission has not been successful. Please accept our apologies and try again later. Details: [details]

Download

Thank you for your interest

You now have access to The current situation in the pharmaceutical industry

A confirmation email has been sent to

Continue to page

Please or get direct access to download this document

The current situation in the pharmaceutical industry

With the goal of fighting the immense market of counterfeit products, several initiatives and legislative measures have been taken or are in the process of being implemented around the world, especially in the pharmaceutical industry.

Initiatives by region/country

EU: Falsified Medicine Directive (FMD) 2011/62/EU for prescription drugs and over the counter (OTC / nonprescription) drugs that may be subject to counterfeiting, to be implemented by Q4 2018.

USA: Drug Quality and Security Act (DQSA) as well as the Drug Supply Chain and Security Act, with an implementation milestone timeline set until 2023.

China: eCode (barcode) by China Food and Drug Administration (CFDA…formerly SFDA).

Turkey, India, Brazil, Australia, others: Various legislations are in place or in preparation.

More information

On Falsified Medicine Directive 2011/62/EU please download the 'Product Traceability' whitepaper.

On general regulations (FDA, HACCP, GMP, etc.) please visit our regulations webpage (tcm:502-31119).